Prevalence and outcome of latent tuberculosis in patients receiving ixekizumab: integrated safety analysis from 11 clinical trials of patients with plaque psoriasis

Artículo

Open/Download

item_85062775358.pdf (1.558Kb)

Publication date

2019

Metadata

Show full item record

Cómo citar

Romiti, R.

Cómo citar

Prevalence and outcome of latent tuberculosis in patients receiving ixekizumab: integrated safety analysis from 11 clinical trials of patients with plaque psoriasisFormato de cita APAISO 690-2ChicagoMLAVancouver

.

Copiar

Cerrar



Author

• Romiti, R.;
• Valenzuela F., Manuel A.;
• Chouela, E. N.;
• Xu, W.;
• Pangallo, B.;
• Moriarty, S. R.;
• Gürbüz, S.;
• Riedl, E.;

Indexation

Artículo de publicación SCOPUS

Identifier

URI: https://repositorio.uchile.cl/handle/2250/171626
DOI: 10.1111/bjd.17604
ISSN: 13652133
00070963

Quote Item

British Journal of Dermatology, Volumen 181, Issue 1, 2019, Pages 202-203

Collections

• Artículos de revistas